Radioembolization of HCC and secondary hepatic tumors: a comprehensive review [0.03%]
肝癌和继发性肝脏肿瘤的放射栓塞治疗综述
Ahmad Arar,Alex Heglin,Shriya Veluri et al.
Ahmad Arar et al.
Transarterial radioembolization (TARE), also called Selective Internal Radiation Therapy (SIRT), has emerged as an effective locoregional therapy for primary and secondary hepatic tumors, utilizing yttrium-90 (Y90) microspheres and other ag...
177Lu-labeled somatostatin receptor targeted radionuclide therapy dosimetry in meningioma: a systematic review [0.03%]
生长抑素受体靶向放射性核素治疗脑膜瘤的剂量学研究系统回顾
Caroline Boursier,Timothée Zaragori,Laëtitia Imbert et al.
Caroline Boursier et al.
Introduction: Few therapeutic options are currently available for refractory meningiomas. Encouraging results have been reported for 177Lu-labeled somatostatin receptor-targeted radiopeptide therapy (SSTR-RT). The current...
Metabolic brain connectivity reorganization in Alzheimer's disease patients: a systematic review [0.03%]
阿尔茨海默病患者代谢性脑连接重构的系统评价研究
Sébastien Heyer,Matthieu Doyen,Antoine Verger
Sébastien Heyer
Introduction: Metabolic connectivity has been studied in various neurodegenerative diseases, particularly Alzheimer's disease (AD), but there is a wealth of accumulated evidence and sometimes conflicting results, dependin...
Correlation of FDG PET/CT, tumor markers and Ki-67 index with EGFR mutation or positive ALK expression in patients with non-small cell lung cancer [0.03%]
非小细胞肺癌患者中FDGPET/CT、肿瘤标志物及Ki-67指数与EGFR突变或ALK阳性表达的关系研究
Hui C Wang,Zhi M Wang,Wei D Hu et al.
Hui C Wang et al.
Background: Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) are the two most common druggable targets in non-small cell lung cancer (NSCLC). To investigate whether the EGFR mutation and ALK re...
Direct comparison of bone marrow biopsy and PET/CT for the detection of bone marrow infiltration in patients with non-Hodgkin lymphoma: a meta-analysis [0.03%]
非霍奇金淋巴瘤患者骨髓浸润检测方法的直接对比：系统性回顾和meta分析
Jie Wang,Qing Zeng
Jie Wang
Background: The diagnostic utility of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) compared to bone marrow biopsy (BMB) in patients with non-Hodgkin lymphoma (NHL) remained to be confi...
Next-level precision medicine: why the theragnostic approach is the future [0.03%]
更高级的精准医疗：为什么“诊疗结合”的方法是未来方向
Aniello Iacomino,Marco Rapa,Gianluca Gatta et al.
Aniello Iacomino et al.
Theragnostics represents one of the most innovative fields of precision medicine with a huge potential in the field of oncology in the next years. The use of a pair of selective radiopharmaceuticals for cellular receptors, used for diagnost...
Predictive value of 18F-fluorodeoxyglucose PET/CT in histological grade of incidental colorectal adenoma [0.03%]
18F-氟脱氧葡萄糖正电子发射断层显像/计算机体层成像对偶然发现的结直肠腺瘤病理分级的预测价值
Yushi Peng,Nina Xu,Yinuo Fu et al.
Yushi Peng et al.
Background: 18F-fluorodeoxyglucose (18F-FDG) positron-emission tomography/computed tomography (PET/CT) as an imaging modality for the whole body has shown its value in detecting incidental colorectal adenoma. In clinical ...
New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy [0.03%]
前列腺癌的新靶向疗法：从放射配体治疗到PARP抑制剂和免疫治疗
Francesco Ceci,Lighea S Airò Farulla,Elena Bonatto et al.
Francesco Ceci et al.
Prostate cancer (PCa) remains a significant global health challenge, particularly in its advanced stages. Despite progress in early detection and treatment, PCa is the second most common cancer diagnosis among men. This review aims to provi...
Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease [0.03%]
前列腺癌：生化复发和寡转移性疾病的功能成像
Lorenzo Muraglia,Egesta Lopci,Jelena Jandric et al.
Lorenzo Muraglia et al.
Introduction: The aim of this article was to offer a comprehensive non-systematic review of the literature about the use of Nuclear Medicine imaging exams for the evaluation of prostate cancer (PCa) in the recurrent setti...
The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment [0.03%]
核医学在前列腺癌管理中的革命：转化诊断和治疗
Laura Evangelista,Francesco Ceci
Laura Evangelista